TCL Archive Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says February 20, 1998
TCL Archive NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin February 1, 2013
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007